En Es
Categories

Industry News


Siemens to List Siemens Healthineers on Frankfurt Stock Exchange

By HospiMedica International staff writers
06 Dec 2017

Image: Siemens AG is preparing to list its separately managed healthcare unit, Siemens Healthineers on the Prime Standard segment of the Frankfurt Stock Exchange's Regulated Market (Photo courtesy of Siemens).Siemens AG (Munich, Germany; Munich), a provider of medical imaging and laboratory diagnostics equipment, is preparing to list its separately managed healthcare unit, Siemens Healthineers (Erlangen, Germany), on the Prime Standard segment of the Frankfurt Stock Exchange's Regulated Market. The move was approved at a meeting by the company's Supervisory Board and has been planned for the first half of 2018. Siemens Healthineers AG will be established for the public listing.

"For Siemens Healthineers, the public listing is the next logical step and the foundation for expanding our strong position as a leading global supplier of healthcare technology," said Michael Sen, Chairman of the Siemens Healthineers Supervisory Board and the member of Siemens' Managing Board responsible, among other things, for healthcare technology. "Frankfurt is one of the world's largest trading centers for securities, and its importance will continue to increase due to Brexit. As a highly liquid trading venue, Frankfurt is attractive for investors from around the world. The public listing will give Siemens Healthineers entrepreneurial flexibility and access to the capital market. The goal is to grow sustainably and profitably while actively shaping the paradigm shift in the healthcare industry."

"Our preparations for the public listing are completely on schedule. The Strategy 2025 concept and the management team are in place. The legal prerequisites have largely been fulfilled," said Siemens Chief Financial Officer Ralf P. Thomas. "Deutsche Bank, Goldman Sachs International and J.P. Morgan have been engaged as global coordinators, and BNP PARIBAS, BofA Merrill Lynch, Citigroup and UBS Investment Bank as further syndicate banks."



E-mail Print
FaceBook Twitter Google+ Linked in

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for the medical industry
Gold member
More info

More articles about Siemens Healthineers

18 Jan 2018
Siemens Healthineers Strategy 2025 to Focus on AI
Siemens Healthineers has laid out its strategy to bolster its market leadership by 2025 and beyond, aimed at accelerating profitable growth and delivering return. The company has stated that it is well prepared to take advantage of the paradigm shift and structural growth opportunities in healthcare.
Read More
18 Dec 2017
Siemens Healthineers Acquires Fast Track Diagnostics
Siemens Healthineers has entered into an agreement to acquire Fast Track Diagnostics, which supplies diagnostics tests that can distinguish between viral, bacterial, or other infections in one test.
Read More
07 Nov 2017
Siemens Healthineers Closes Epocal Acquisition
Siemens Healthineers, the separately managed healthcare business of Siemens AG, has completed the acquisition of Epocal Inc., a subsidiary of Alere Inc. that develops and provides point-of-care (POC) blood diagnostic systems for healthcare enterprises.
Read More
16 Oct 2017
Siemens Healthineers Enters Agreement with HORIBA Medical
Siemens Healthineers and HORIBA Medical have entered into a long-term agreement to bring new and innovative hematology solutions to the market globally.
Read More
24 Jul 2017
Siemens to Acquire Blood Gas Subsidiary of Alere
Siemens Healthineers, the separately managed healthcare business of Siemens AG, has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. that develops and provides point-of-care (POC) blood diagnostic systems for healthcare enterprises.
Read More
28 Jun 2017
Alliance Formed to Digitalize Medicine and Healthcare
The Universitätsklinikum Erlangen, Siemens Healthineers (Erlangen, Germany), the Friedrich-Alexander-Universität-Erlangen-Nürnberg (FAU), the Fraunhofer Institute for Integrated Circuits (IIS), and Medical Valley EMN have entered into an alliance to establish the Digital Health Innovation Platform (d.hip) with the aim of driving digitalization in medicine and healthcare.
Read More
14 Jun 2017
Siemens Healthineers and Fast-track Diagnostics Form Strategic Relationship
Siemens Healthineers, the separately managed healthcare business of Siemens AG, has entered into a new strategic relationship with Fast-track Diagnostics for the addition of FTD’s broad range of CE-marked kits and multi-syndromic panels to the menu of Siemens Healthineers’ VERSANT kPCR Molecular System. This will allow Siemens Healthineers to provide its customers with expanded, more comprehensive molecular testing solutions.
Read More
26 Apr 2017
Siemens Healthineers Acquires Medicalis to Expand PHM Portfolio
Siemens Healthineers has signed an agreement to acquire Medicalis Corporation with the aim of expanding its Population Health Management (PHM) portfolio.
Read More

Additional news

13 Feb 2018
QIAGEN Enters into Agreement to Acquire STAT-Dx
QIAGEN N.V. has entered into an agreement to acquire STAT-Dx, a privately-held company which develops next generation of multiplex diagnostics for one-step, fully integrated molecular analysis of common syndromes using a novel system based on real-time PCR technology and proven QIAGEN chemistries.
Read More
08 Feb 2018
AI Could Learn How to Understand Radiologist Reports
Researchers at the Icahn School of Medicine at Mount Sinai have used machine learning techniques, including natural language processing algorithms, to identify clinical concepts in radiologist reports for computed tomography (CT) scans. The technology marks an important first step in the development of artificial intelligence (AI) that could interpret scans and diagnose conditions.
Read More
08 Feb 2018
AR and VR in Healthcare Market to Reach USD 4.9 Million by 2023
The augmented reality (AR) and virtual reality (VR) in the healthcare market was valued at USD 769.2 million in 2017 and is expected to grow at a CAGR of 36.6% during the forecast period to reach USD 4,997.9 million by 2023. The market growth will be driven by increasing penetration of connected devices in the healthcare sector, rising investment in healthcare AR and VR, and growing need to reduce healthcare costs. However, the lack of competence in the deployment of AR and VR solutions, and lack of expertise among medical practitioners to adopt new technologies are the major restraints for market growth.
Read More
08 Feb 2018
Elekta Collaborates with IBM Watson Health to Bring AI to Oncology
Elekta is collaborating with IBM Watson Health to offer Watson for Oncology with its cancer care solutions. Beginning in early 2018, Elekta will sell Watson for Oncology as a clinical decision support solution, paired within its digital cancer care solutions, including the MOSAIQ Oncology Information System.
Read More
08 Feb 2018
AR System Allows Surgeons to Reconnect Blood Vessels
A team of researchers at Imperial College London at St Mary’s Hospital has demonstrated the use of Microsoft HoloLens headset for performing reconstructive lower limb surgery on patients. The HoloLens is a self-contained computer headset that immerses the wearer in ‘mixed reality’, allowing them to interact with ‘holograms’ which are computer-generated objects made visible through the visor.
Read More
29 Jan 2018
Top Drivers of Global Laboratory Centrifuge Market
The global laboratory centrifuge market is expected to grow steadily at a CAGR of more than 5% during the forecast period 2017-2022, driven mainly by the increasing number of biotechnology and pharmaceutical research studies, growing use of molecular diagnostics in hospitals, and technological advancements.
Read More
29 Jan 2018
Patient Positioning Systems Market to Reach USD 1.4 Billion by 2025
The global patient positioning systems market was valued at USD 942.8 million in 2016 and is expected to grow at a CAGR of 4.7% during the 2014 - 2025 forecast period to reach USD 1.4 billion by 2025, driven by a growing geriatric population, rising incidence of cancer, increasing awareness among patients, and surge in expenditure on diagnostic procedures. Additionally, technological advancements in sensors, such as optic fiber technology, cancer tracking sensors, and MEMS sensors, are expected to further boost the market growth.
Read More
16 Jan 2018
GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
GE Healthcare and Roche have entered into a strategic, long-term partnership to jointly develop and co-market digital clinical decision support solutions. Initially, the partnership will focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.
Read More
16 Jan 2018
Global Ultrasound Market to Reach USD 6.86 Billion by 2021
The global ultrasound market is expected to grow at a CAGR of 5.2% during 2016 to 2021 to reach a value of USD 6.86 billion by 2021, driven by a growing patient population base for chronic and lifestyle-related disorders, technological advancements, and increasing demand for minimally invasive diagnostic and therapeutic techniques.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions